These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38904389)

  • 1. Efficacy of ivermectin and its metabolites against
    Annamalai Subramani P; Tipthara P; Kolli SK; Nicholas J; Barnes SJ; Ogbondah MM; Kobylinski KC; Tarning J; Adams JH
    Antimicrob Agents Chemother; 2024 Jun; ():e0127223. PubMed ID: 38904389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the metabolites of ivermectin in humans.
    Tipthara P; Kobylinski KC; Godejohann M; Hanboonkunupakarn B; Roth A; Adams JH; White NJ; Jittamala P; Day NPJ; Tarning J
    Pharmacol Res Perspect; 2021 Feb; 9(1):e00712. PubMed ID: 33497030
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.
    Yipsirimetee A; Tipthara P; Hanboonkunupakarn B; Tripura R; Lek D; Kümpornsin K; Lee MCS; Sattabongkot J; Dondorp AM; White NJ; Kobylinski KC; Tarning J; Chotivanich K
    Antimicrob Agents Chemother; 2023 Jul; 67(7):e0173022. PubMed ID: 37338381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of ivermectin metabolites and their activity against Anopheles stephensi mosquitoes.
    Kern C; Müller P; Chaccour C; Liechti ME; Hammann F; Duthaler U
    Malar J; 2023 Jun; 22(1):194. PubMed ID: 37355605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ivermectin metabolites reduce Anopheles survival.
    Kobylinski KC; Tipthara P; Wamaket N; Chainarin S; Kullasakboonsri R; Sriwichai P; Phasomkusolsil S; Hanboonkunupakarn B; Jittamala P; Gemmell R; Boyle J; Wrigley S; Steele J; White NJ; Tarning J
    Sci Rep; 2023 May; 13(1):8131. PubMed ID: 37208382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized feasibility trial comparing four antimalarial drug regimens to induce
    Reuling IJ; van de Schans LA; Coffeng LE; Lanke K; Meerstein-Kessel L; Graumans W; van Gemert GJ; Teelen K; Siebelink-Stoter R; van de Vegte-Bolmer M; de Mast Q; van der Ven AJ; Ivinson K; Hermsen CC; de Vlas S; Bradley J; Collins KA; Ockenhouse CF; McCarthy J; Sauerwein RW; Bousema T
    Elife; 2018 Feb; 7():. PubMed ID: 29482720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety, Pharmacokinetics, and Activity of High-Dose Ivermectin and Chloroquine against the Liver Stage of Plasmodium cynomolgi Infection in Rhesus Macaques.
    Vanachayangkul P; Im-Erbsin R; Tungtaeng A; Kodchakorn C; Roth A; Adams J; Chaisatit C; Saingam P; Sciotti RJ; Reichard GA; Nolan CK; Pybus BS; Black CC; Lugo-Roman LA; Wegner MD; Smith PL; Wojnarski M; Vesely BA; Kobylinski KC
    Antimicrob Agents Chemother; 2020 Aug; 64(9):. PubMed ID: 32660993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of Plasmodium Liver Infection by Ivermectin.
    Mendes AM; Albuquerque IS; Machado M; Pissarra J; Meireles P; Prudêncio M
    Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27895022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and interactions of Ivermectin with human cytochrome P450 enzymes and drug transporters, possible adverse and toxic effects.
    Rendic SP
    Arch Toxicol; 2021 May; 95(5):1535-1546. PubMed ID: 33719007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro susceptibility and ex-vivo evaluation of macrocyclic lactone endectocides sub-lethal concentrations against Plasmodium vivax oocyst development in Anopheles arabiensis.
    Zeleke G; Duchateau L; Yewhalaw D; Suleman S; Devreese M
    Malar J; 2024 Jan; 23(1):26. PubMed ID: 38238768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ivermectin Impairs the Development of Sexual and Asexual Stages of Plasmodium falciparum
    de Carvalho LP; Sandri TL; José Tenório de Melo E; Fendel R; Kremsner PG; Mordmüller B; Held J
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31109978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytochrome P450/ABC transporter inhibition simultaneously enhances ivermectin pharmacokinetics in the mammal host and pharmacodynamics in Anopheles gambiae.
    Chaccour CJ; Hammann F; Alustiza M; Castejon S; Tarimo BB; Abizanda G; Irigoyen Barrio Á; Martí Soler H; Moncada R; Bilbao JI; Aldaz A; Maia M; Del Pozo JL
    Sci Rep; 2017 Aug; 7(1):8535. PubMed ID: 28819225
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery of FNDR-20123, a histone deacetylase inhibitor for the treatment of Plasmodium falciparum malaria.
    Potluri V; Shandil RK; Gavara R; Sambasivam G; Campo B; Wittlin S; Narayanan S
    Malar J; 2020 Oct; 19(1):365. PubMed ID: 33046062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and mosquitocidal efficacy of high-dose ivermectin when co-administered with dihydroartemisinin-piperaquine in Kenyan adults with uncomplicated malaria (IVERMAL): a randomised, double-blind, placebo-controlled trial.
    Smit MR; Ochomo EO; Aljayyoussi G; Kwambai TK; Abong'o BO; Chen T; Bousema T; Slater HC; Waterhouse D; Bayoh NM; Gimnig JE; Samuels AM; Desai MR; Phillips-Howard PA; Kariuki SK; Wang D; Ward SA; Ter Kuile FO
    Lancet Infect Dis; 2018 Jun; 18(6):615-626. PubMed ID: 29602751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of combined drug treatments on Plasmodium falciparum: In vitro assays with doxycycline, ivermectin and efflux pump inhibitors.
    Nodari R; Corbett Y; Varotto-Boccazzi I; Porretta D; Taramelli D; Epis S; Bandi C
    PLoS One; 2020; 15(4):e0232171. PubMed ID: 32324826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ivermectin susceptibility, sporontocidal effect, and inhibition of time to re-feed in the Amazonian malaria vector Anopheles darlingi.
    Kobylinski KC; Escobedo-Vargas KS; López-Sifuentes VM; Durand S; Smith ES; Baldeviano GC; Gerbasi RV; Ballard SB; Stoops CA; Vásquez GM
    Malar J; 2017 Nov; 16(1):474. PubMed ID: 29162101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing drug efficacy against Plasmodium falciparum liver stages in vivo.
    Flannery EL; Foquet L; Chuenchob V; Fishbaugher M; Billman Z; Navarro MJ; Betz W; Olsen TM; Lee J; Camargo N; Nguyen T; Schafer C; Sack BK; Wilson EM; Saunders J; Bial J; Campo B; Charman SA; Murphy SC; Phillips MA; Kappe SH; Mikolajczak SA
    JCI Insight; 2018 Jan; 3(1):. PubMed ID: 29321371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Thienopyrimidinone Chemotype Shows Multistage Activity against Plasmodium falciparum, Including Artemisinin-Resistant Parasites.
    Bosson-Vanga H; Primas N; Franetich JF; Lavazec C; Gomez L; Ashraf K; Tefit M; Soulard V; Dereuddre-Bosquet N; Le Grand R; Donnette M; Mustière R; Amanzougaghene N; Tajeri S; Suzanne P; Malzert-Fréon A; Rault S; Vanelle P; Hutter S; Cohen A; Snounou G; Roques P; Azas N; Lagardère P; Lisowski V; Masurier N; Nguyen M; Paloque L; Benoit-Vical F; Verhaeghe P; Mazier D
    Microbiol Spectr; 2021 Oct; 9(2):e0027421. PubMed ID: 34724729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ketoconazole, a cytochrome P(450) inhibitor can potentiate the antimalarial action of α/β arteether against MDR Plasmodium yoelii nigeriensis.
    Tripathi R; Rizvi A; Pandey SK; Dwivedi H; Saxena JK
    Acta Trop; 2013 May; 126(2):150-5. PubMed ID: 23391499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.